Eriksson S, Piitulainen E, Carlson J, Jeppsson J-O. Nationell samordning nödvändig för ökad kunskap om alpha1-antitrypsinbrist. Läkartidningen 1990;87:2105-10.
Eriksson S, Piitulainen E. Alpha1-antitrypsinregistret behövs. Klinisk uppföljning av patienter underlättas. Läkartidningen 1994;91:3510-16.
Sveger T, Piitulainen E, Arborelius Jr M. Lung function in adolescents with alpha1- antitrypsin deficiency. Acta Paediatr 1994;83:1170-73.
Elzouki A-N, Segelmark S, Wieslander J, Eriksson S. Strong link between the alpha1- antitrypsin PiZ allele and Wegener’s granulomatosis. J Intern Med 1994;236:543-48.
Sveger T, Piitulainen E, Arborelius Jr M. Alpha1-antitrypsin deficiency: Clinical features and lung function in 18-year-old adolescents with alpha1-antitrypsin deficiency. Acta Paediatr 1995;84:815-6.
Sveger T, Eriksson S. The liver in adolescents with alpha1-antitrypsin deficiency. Hepatology 1995;22:514-17
Elzouki A-N, Hultcrantz R, Stål P, Befrits R, Eriksson S. Increased PiZ gene frequency for alpha1-antitrypsin in patients with genetic haemochromatosis. Gut 1995;36:922
Segelmark S, Elzouki A-N, Wieslander J, Eriksson S. The PiZ gene of alpha1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int 1995;48:844- 50.
Elzouki A-N, Eriksson S. Risk of hepatobiliary diseases in adults with severe alpha1- antitrypsin deficiency (PiZZ): Is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma? Eur J Gastroenterol & Hepatol 1996;8:989- 94.
Mazodier R, Elzouki A-N, Segelmark M, Eriksson S. Systemic necrotizing vasculitides in severe alpha1-antitrypsin deficiency. Q J Med 1996;89:599-611.
Piitulainen E, Tornling G, Eriksson S. Effect of age and occupational exposure to irritants on lung function in non-smoking individuals with alpha1-antitrypsin deficiency (PiZZ). Thorax 1997;52:244-8.
Rydén Ahlgren Å, Piitulainen E, Sonesson B, Länne T. Changes in aortic wall stiffness in men with alpha1-antitrypsin deficiency. Eur J Vasc Endovasc Surg 1997;14:252-7.
Elzouki A-N, Verbaan H, Lindgren S, Widell A, Carlson J, Eriksson S. Serpins in patients with chronic viral hepatitis. J Hepatology 1997;27:42-8.
Sveger T, Ohlsson K, Piitulainen E. Adolescents with alpha1-antitrypsin deficiency have high α2-macroglobulin and low neutrophil lipocalin and elastase levels in plasma. Pediatric Research; Dec 1998;44:939-41
Piitulainen E, Tornling G, Eriksson S. Environmental correlates of impaired lung function in non-smokers with severe alpha1-antitrypsin deficiency (PiZZ). Thorax 1998; 53:939-43. Publikationer AAT-registret
Piitulainen E, Sveger T. Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha1-antitrypsin deficiency. Acta Paediatr. 1998 Nov;87(11)1120-4.
Piitulainen E, Areberg J, Lindén M, Eriksson S, Mattsson S, Wollmer P. Total body protein and muscle strength in emphysema patients with special reference to alpha1- antitrypsin deficiency (PiZZ). Eur Respir J 1999; 13:247-251.
Piitulainen E, Eriksson S. Decline in FEV1 by age and smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). Eur Resp J February 1, 1999; 13 no. 2, 247- 251.
Piitulainen E, Eriksson S. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). Eur Resp J 1999; 13:247-51.
Piitulainen E, Sveger T. Respiratory symptoms and lung function in young adults with severe alpha1-antitrypsin deficiency (PiZZ). Thorax 2002; 57:705-8
Piitulainen E, Areberg J, Lindén M, Eriksson S, Mattsson S and Wollmer P. Nutritional status and muscle strength in emphysema patients with severe alpha1-antitrypsin deficiency (PiZZ). Chest 2002 Oct;122(4):1240-1246
Janciauskiene S, Dominaitiene R, Sternby NH, Piitulainen E, Eriksson S. Detection of circulating and endothelial cell polymers of Z and wild type alpha1-antitrysin by a monoclonal antibody. J Biol Chem 2002; 277(29):26540-6
Berntorp E, Piitulainen E, Lethagen S, Mattson E, Tengborn L, Mätzsch T. Experience with a new percutaneous port system, Percuseal, for intravenous injection in patients with haemophilia, von Willebrand disease and severe alpha1-antitrypsin deficiency. Haemophilia 2003; 9:173-8.
Piitulainen E, Bernspång E, Björkman S, Berntorp E. Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha-1-antitrypsin. Eur J Clin Pharmacol 2003;59:151-6.
Stoel BC, Bakker ME, Stolk J, Dirksen A, Stockley RA, Piitulainen E, Russi EW, Reiber JH. Comparison of the Sensitivities of 5 Different Computed Tomography Scanners for the Assessment of the Progression of Pulmonary Emphysema: A Phantom Study. Invest Radiol 2004 Jan;39(1):1-7
Aldonyte R, Jansson L, Piitulainen E, Janciauskiene S. Circulating monocytes from healthy individuals and COPD patients. Respir Res 2003;4(1):11. Epub 2003 Sep 22.
Zelvyte I, Wallmark A, Piitulainen E, Westin U, Janciauskiene S. Increased plasma levels of serine proteinase inhibitors in lung cancer patients. Anticancer Res 2004;24(1):241-7.
Aldonyte R, Eriksson S, Piitulainen E, Wallmark A, Janciauskiene S. Analysis of systemic biomarkers in COPD patients. COPD: Journal of chronic obstructive pulmonary disease 2004;1:155-164
Piitulainen E, Carlson J, Ohlsson K, Sveger T. α1-Antitrypsin Deficiency in 26-year-old Subjects. Lung, Liver, and Protease/Protease Inhibitor Studies. Chest 2005;128:2076-81
Bakker ME, Stolk J, Putter H, Shaker SB, Parr DG, Piitulainen E, Russi EW, Dirksen A, Stockley RA , Reiber JH, Stoel BC. Variability in Densitometric Assessment of Pulmonary Emphysema with Computed Tomography. Invest Radiol 2005;40:777-783.
Stockley RA, Luisetti M, Miravitlles M, Piitulainen E, Fernandez P, Alpha-1-antitrypsin deficiency International Registry group. Ongoing research in Europe: Alpha-1- antitrypsin deficiency International Registry (AIR) objectives and development. Eur Respir J 2007; 29:582-6.
Hollander C, Westin U, Wallmark A, Piitulainen E, Sveger T, Janciauskiene SM. Plasma levels of alpha1-antichymotrypsin and sectretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency. BMC Pulm Med 2007;7:1.
Bernspång E, Sveger T, Piitulainen E. Respiratory symptoms and lung function in 30- year-old individuals with alpha-1-antitrypsin deficiency. Respir Med 2007; 101:1971-6.
Stolk J, Putter H, Bakker EM, Shaker SB, Parr DG, Piitulainen E, Russi EW, Grebski E, Dirksen A, Stockley RA, Reiber JHC, Stoel BC. Progression parameters for emphysema: a clinical investigation. Respir Med 2007; 101(9):1924-30
Piitulainen E, Löfdahl CG. Alpha 1-antitrypsin and therapeutic evidence. Läkartidningen. 2008; 105:233
Sandström CS, Novoradovskaya N, Cilio CM, Piitulainen E, Sveger T, Janciauskiene S. Endotoxin receptor CD14 in PiZ alpha-1-antitrypsin deficiency individuals. Respir Res. 2008 Apr 21;9:34.
Tanash HA, Nilsson PM, Nilsson JA, Piitulainen E. Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ). Thorax. 2008 Dec;63(12):1091-5.
Bernspång E, Wollmer P, Sveger T, Piitulainen E. Lung function in 30-year-old alpha-1- antitrypsin-deficient individuals. Respir Med. 2009;103(6):861-5.
Dirksen A, Piitulainen E, Parr DG, Deng C, Wencker M, Shaker SB, Stockley RA. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Eur Repir J. 2009;33(6):1345-53.
Parr DG, Dirksen A, Piitulainen E, Deng C, Wencker M, Stockley RA. Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antritrypsin deficiency. Respir Res. 2009;10:75.
Bernspång E, Carlsson J, Piitulainen E. The liver in 30-year-old individuals with alpha(1)-antitrypsin deficiency. Scand J Gastroenterol. 2009;44:1349-55.
Tanash HA, Nilsson PM, Nilsson JA, Piitulainen E. Survival in severe alpha-1- antitrypsin deficiency (PiZZ). Respir Res. 2010 Apr 26;11-44.
Bernspång E, Diaz S, Stoel B, Wollmer P, Sveger T, Piitulainen E. CT lung densitometry in young adults with alpha-1-antitrypsin deficiency. Respir Med. 2010;105:74-9.
Janciauskiene S, Subramaniyam D, Piitulainen E, Köhnlein T, Sveger T. Plasma levels of TIMP-1 are higher in 34-year-old individuals with severe alfa1-antitrypsin deficiency. Thorax. 2010 Okt;65(10):937. Epub 2010 Sep 3.
Stockley RA, Parr DG, Piitulainen E, Stolk J, Stoel BC, Dirksen A. Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densiometry. Respir Res 2010, 11:136
Wallin-Bengtsson V, Piitulainen E, Hamberg K, Lindh C, Bratthall G. Alpha-1- antitrypsin deficiency and periodontitis, a pilot study. Swed Dent J 2011; 35: 33-40.
Janciauskiene S, Subramaniyam D, Piitulainen E, Köhnlein T, Sveger T. Plasma levels of TIMP-1 are higher in 34-year-old individuals with severe α1-antitrypsin deficiency. Thorax. 2010 Oct;65(10):937. Epub 2010 Sep 3. No abstract available.
Carter RI, Mumford RA, Treonze, KM, Finke PE, Davies P, Si Q, Humes JL, Dirksen A, Piitulainen E, Ahmad A, Stockley RA. The fibrinogen cleavage product A(alpha)-Val360, a specific marker of neutrophil elastase activity in vivo. Thorax 2011 May 26.
Janciauskiene S, Wallmark A, Piitulainen E, Köhnlein T, Welte T, Sveger T. Performance of enhanced liver fibrosis plasma markers in asymptomatic individuals with ZZ alfa1-antitrypsin deficiency. Eur Journal of Gastroenterology & Hepatology 2011.
Hanan A.Tanash, Gerdt C. Riise, Lennart Hansson, Peter M. Nilsson, Eeva Piitulainen. Survival benefit of lung transplantation in individuals with severe alfa1-antitrypsin deficiency (PiZZ) and emphysema. The Journal of Heart and Lung Transplantation. In press.
